Insider Transactions in Q1 2021 at Lexicon Pharmaceuticals, Inc. (LXRX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2021
|
James F Tessmer VP, Finance & Accounting |
SELL
Open market or private sale
|
Direct |
22,912
-13.76%
|
$137,472
$6.91 P/Share
|
|
Mar 15
2021
|
James F Tessmer VP, Finance & Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+12.53%
|
$36,000
$3.31 P/Share
|
|
Feb 28
2021
|
Lonnel Coats Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
55,038
-11.19%
|
$385,266
$7.19 P/Share
|
|
Feb 28
2021
|
Lonnel Coats Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
192,885
+9.86%
|
-
|
|
Feb 28
2021
|
Brian T Crum SVP, General Counsel & Secr. |
SELL
Payment of exercise price or tax liability
|
Direct |
14,860
-16.79%
|
$104,020
$7.19 P/Share
|
|
Feb 28
2021
|
Brian T Crum SVP, General Counsel & Secr. |
BUY
Exercise of conversion of derivative security
|
Direct |
38,765
+11.13%
|
-
|
|
Feb 28
2021
|
Alan J Main EVP, Innov & Chem Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
20,413
-12.67%
|
$142,891
$7.19 P/Share
|
|
Feb 28
2021
|
Alan J Main EVP, Innov & Chem Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
56,468
+8.9%
|
-
|
|
Feb 28
2021
|
James F Tessmer VP, Finance & Accounting |
SELL
Payment of exercise price or tax liability
|
Direct |
10,765
-11.52%
|
$75,355
$7.19 P/Share
|
|
Feb 28
2021
|
James F Tessmer VP, Finance & Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
28,316
+7.64%
|
-
|
|
Feb 28
2021
|
Praveen Tyle EVP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
16,560
-12.06%
|
$115,920
$7.19 P/Share
|
|
Feb 28
2021
|
Praveen Tyle EVP, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
68,007
+12.88%
|
-
|
|
Feb 28
2021
|
Jeffrey L Wade President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,584
-14.48%
|
$186,088
$7.19 P/Share
|
|
Feb 28
2021
|
Jeffrey L Wade President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
68,109
+9.42%
|
-
|